OR WAIT null SECS
© 2021 MJH Life Sciences and Ophthalmology Times. All rights reserved.
© 2021 MJH Life Sciences™ and Ophthalmology Times. All rights reserved.
Since the release of the topical beta-blocker timolol maleate (Timoptic, Merck) some 2 decades ago, glaucoma patients have been the beneficiaries of a cascade of new IOP-lowering pharmaceuticals.